Evidence map›Paper›PMID 27096708›Full record

ArticleCOPD2016

Implementation of a COPD Screening Questionnaire in an Outpatient HIV Clinic.

Allison A Lambert, M Bradley Drummond, Annamarie Kisalu, John Moxley, Jeanne Keruly, Richard D Moore, Robert A Wise, Gregory D Kirk

Open access · greenAbstract read
In one paragraph

Article in COPD, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. HIV-associated lung disease.Nature reviews. Disease primers · 2023
    Review
  5. COPD in People with HIV: Epidemiology, Pathogenesis, Management, and Prevention Strategies.International journal of chronic obstructive pulmonary disease · 2023
    Review
  6. Chronic obstructive pulmonary disease in HIV.Expert review of respiratory medicine · 2021
    Review
  7. Article
  8. Article
  9. The 'missing millions': Where do we find them?Chronic respiratory disease · 2016
    Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Allison A Lamberta Department of Medicine , Division of Pulmonary and Critical Care, Johns Hopkins University , Baltimore , Maryland , USA.
M Bradley Drummonda Department of Medicine , Division of Pulmonary and Critical Care, Johns Hopkins University , Baltimore , Maryland , USA.
Annamarie Kisalub Department of Epidemiology ; Johns Hopkins University , Baltimore , Maryland , USA.
John Moxleyb Department of Epidemiology ; Johns Hopkins University , Baltimore , Maryland , USA.
Jeanne Kerulyc Department of Medicine , Division of Infectious Diseases, Johns Hopkins University , Baltimore , Maryland , USA.
Richard D Moorec Department of Medicine , Division of Infectious Diseases, Johns Hopkins University , Baltimore , Maryland , USA.
Robert A Wisea Department of Medicine , Division of Pulmonary and Critical Care, Johns Hopkins University , Baltimore , Maryland , USA.
Gregory D Kirkb Department of Epidemiology ; Johns Hopkins University , Baltimore , Maryland , USA.
Johns Hopkins University · USJohns Hopkins Medicine · US

Funding

Vaccine Response and Immunotherapeutics SWGP30AI094189 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Richard E. Chaisson · 2012 to 2026
$67.0M
The AIDS Linked to the Intravenous Experience (ALIVE) StudyU01DA036297 · NIDA · JOHNS HOPKINS UNIVERSITY · PI Gregory D Kirk, Shruti H Mehta · 2014 to 2026
$28.9M
MULTIDISCIPLINARY TRAINING PROGRAM IN LUNG DISEASEST32HL007534 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI Nadia N Hansel, Larissa A. Shimoda · 1985 to 2026
$28.3M
INCIDENCE OF HIV INFECTIONS IN A COHORT OF IV DRUG USERSR01DA012568 · NIDA · JOHNS HOPKINS UNIVERSITY · PI MEHTA, SHRUTI H · 1999 to 2017
$15.5M
Johns Hopkins HIV Clinical CohortU01DA036935 · NIDA · JOHNS HOPKINS UNIVERSITY · PI MOORE, RICHARD DOUGLAS · 2014 to 2024
$14.9M
Institute for Clinical and Translational ResearchKL2TR001077 · NCATS · JOHNS HOPKINS UNIVERSITY · PI FORD, DANIEL ERNEST · 2013 to 2017
$9.2M
The Study of HIV Infection in the Etiology of Lung Disease (SHIELD)R01HL090483 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI KIRK, GREGORY D · 2007 to 2011
$4.4M
Immune Mechanisms of HIV-associated COPDU01HL121814 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI KIRK, GREGORY D, MCDYER, JOHN F · 2013 to 2017
$3.5M
Predictors, consequences and mechanisms of accelerated lung aging in HIVR01HL126549 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI KIRK, GREGORY D · 2014 to 2018
$3.2M
Using mHealth to Respond Early to Acute Exacerbations of COPD in HIV_ mREACHR34HL117349 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI KIRK, GREGORY D · 2012 to 2013
$1.3M
Patient-Oriented Research and Mentorship in HIV and Non-Communicable DiseasesK24AI118591 · NIAID · JOHNS HOPKINS UNIVERSITY · PI KIRK, GREGORY D · 2015 to 2019
$766k
NCATS NIH HHS KL2 TR001077NHLBI NIH HHS R01 HL090483NHLBI NIH HHS R01 HL126549NHLBI NIH HHS R34 HL117349NHLBI NIH HHS T32 HL007534NHLBI NIH HHS U01 HL121814NIAID NIH HHS K24 AI118591NIAID NIH HHS P30 AI094189NIDA NIH HHS R01 DA012568NIDA NIH HHS U01 DA036297NIDA NIH HHS U01 DA036935
6 · The paper itself

Abstract

Human immunodeficiency virus (HIV) is associated with increased risk for chronic obstructive pulmonary disease (COPD); yet substantial under-recognition of COPD exists. We administered a patient-completed, physician-reviewed COPD screening tool in an outpatient HIV clinic to determine whether screening is feasible or possible. Patients attending nonacute, routine HIV care visits were provided a brief COPD screening tool, which included three questions focused on age, respiratory symptoms, and smoking history. Providers were given completed forms for review and ordered spirometry at their discretion. Forms and medical records were subsequently reviewed to determine completion and results of spirometry testing. Of the 1,510 patients screened during the study period, 968 (64%) forms were completed. After excluding 79 incomplete forms, 889 (92%) unique patient forms were included in this analysis. Among these, 204 (23%) met criteria for spirometry referral, among whom physicians ordered spirometry in 64 (31%). At 6 months following study completion, 19 (30%) of the patients referred for spirometry had the test completed, with 5 (26%) demonstrating airflow obstruction. Nearly one out of four HIV patients met indication for screening spirometry and roughly one out of four undergoing spirometry had COPD. Critical drop-offs in the screening and diagnostic process occurred at questionnaire completion and spirometry ordering. Interventions tailored to these critical steps could improve the yield from COPD screening and help to optimize the identification of COPD in high-risk HIV-infected populations. COPD screening in a clinic focused on longitudinal HIV care can effectively identify COPD among those completing the screening continuum.

Indexed as

Surveys and QuestionnairesAdultAmbulatory Care FacilitiesFemaleHIV InfectionsHumansMaleMass ScreeningMiddle AgedPulmonary Disease, Chronic ObstructiveReferral and ConsultationSpirometryContinuumdiagnosisfeasiblespirometry

Identifiers

PMID27096708
PMCPMC5073036
OpenAlexW2340997170

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.